RFTS-deleted DNMT1 enhances tumorigenicity with focal hypermethylation and global hypomethylation

Bo Kuan Wu, Szu Chieh Mei, Charles Brenner

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Site-specific hypermethylation of tumor suppressor genes accompanied by genome-wide hypomethylation are epigenetic hallmarks of malignancy. However, the molecular mechanisms that drive these linked changes in DNA methylation remain obscure. DNA methyltransferase 1 (DNMT1), the principle enzyme responsible for maintaining methylation patterns is commonly dysregulated in tumors. Replication foci targeting sequence (RFTS) is an N-terminal domain of DNMT1 that inhibits DNA-binding and catalytic activity, suggesting that RFTS deletion would result in a gain of DNMT1 function. However, a substantial body of data suggested that RFTS is required for DNMT1 activity. Here, we demonstrate that deletion of RFTS alters DNMT1-dependent DNA methylation during malignant transformation. Compared to full-length DNMT1, ectopic expression of hyperactive DNMT1-DRFTS caused greater malignant transformation and enhanced promoter methylation with condensed chromatin structure that silenced DAPK and DUOX1 expression. Simultaneously, deletion of RFTS impaired DNMT1 chromatin association with pericentromeric Satellite 2 (SAT2) repeat sequences and produced DNA demethylation at SAT2 repeats and globally. To our knowledge, RFTS-deleted DNMT1 is the first single factor that can reprogram focal hypermethylation and global hypomethylation in parallel during malignant transformation. Our evidence suggests that the RFTS domain of DNMT1 is a target responsible for epigenetic changes in cancer.

Original languageEnglish (US)
Pages (from-to)3222-3231
Number of pages10
JournalCell Cycle
Volume13
Issue number20
DOIs
StatePublished - Oct 15 2014
Externally publishedYes

Fingerprint

Methyltransferases
DNA
DNA Methylation
Epigenomics
Methylation
Chromatin
Catalytic DNA
Neoplasms
Sequence Deletion
Tumor Suppressor Genes
Genome

Keywords

  • Chromatin
  • DNA methylation
  • DNMT1
  • RFTS domain
  • Tumorigenicity

ASJC Scopus subject areas

  • Molecular Biology
  • Developmental Biology
  • Cell Biology

Cite this

RFTS-deleted DNMT1 enhances tumorigenicity with focal hypermethylation and global hypomethylation. / Wu, Bo Kuan; Mei, Szu Chieh; Brenner, Charles.

In: Cell Cycle, Vol. 13, No. 20, 15.10.2014, p. 3222-3231.

Research output: Contribution to journalArticle

@article{828064095b26459ea9259decc1b58314,
title = "RFTS-deleted DNMT1 enhances tumorigenicity with focal hypermethylation and global hypomethylation",
abstract = "Site-specific hypermethylation of tumor suppressor genes accompanied by genome-wide hypomethylation are epigenetic hallmarks of malignancy. However, the molecular mechanisms that drive these linked changes in DNA methylation remain obscure. DNA methyltransferase 1 (DNMT1), the principle enzyme responsible for maintaining methylation patterns is commonly dysregulated in tumors. Replication foci targeting sequence (RFTS) is an N-terminal domain of DNMT1 that inhibits DNA-binding and catalytic activity, suggesting that RFTS deletion would result in a gain of DNMT1 function. However, a substantial body of data suggested that RFTS is required for DNMT1 activity. Here, we demonstrate that deletion of RFTS alters DNMT1-dependent DNA methylation during malignant transformation. Compared to full-length DNMT1, ectopic expression of hyperactive DNMT1-DRFTS caused greater malignant transformation and enhanced promoter methylation with condensed chromatin structure that silenced DAPK and DUOX1 expression. Simultaneously, deletion of RFTS impaired DNMT1 chromatin association with pericentromeric Satellite 2 (SAT2) repeat sequences and produced DNA demethylation at SAT2 repeats and globally. To our knowledge, RFTS-deleted DNMT1 is the first single factor that can reprogram focal hypermethylation and global hypomethylation in parallel during malignant transformation. Our evidence suggests that the RFTS domain of DNMT1 is a target responsible for epigenetic changes in cancer.",
keywords = "Chromatin, DNA methylation, DNMT1, RFTS domain, Tumorigenicity",
author = "Wu, {Bo Kuan} and Mei, {Szu Chieh} and Charles Brenner",
year = "2014",
month = "10",
day = "15",
doi = "10.4161/15384101.2014.950886",
language = "English (US)",
volume = "13",
pages = "3222--3231",
journal = "Cell Cycle",
issn = "1538-4101",
publisher = "Landes Bioscience",
number = "20",

}

TY - JOUR

T1 - RFTS-deleted DNMT1 enhances tumorigenicity with focal hypermethylation and global hypomethylation

AU - Wu, Bo Kuan

AU - Mei, Szu Chieh

AU - Brenner, Charles

PY - 2014/10/15

Y1 - 2014/10/15

N2 - Site-specific hypermethylation of tumor suppressor genes accompanied by genome-wide hypomethylation are epigenetic hallmarks of malignancy. However, the molecular mechanisms that drive these linked changes in DNA methylation remain obscure. DNA methyltransferase 1 (DNMT1), the principle enzyme responsible for maintaining methylation patterns is commonly dysregulated in tumors. Replication foci targeting sequence (RFTS) is an N-terminal domain of DNMT1 that inhibits DNA-binding and catalytic activity, suggesting that RFTS deletion would result in a gain of DNMT1 function. However, a substantial body of data suggested that RFTS is required for DNMT1 activity. Here, we demonstrate that deletion of RFTS alters DNMT1-dependent DNA methylation during malignant transformation. Compared to full-length DNMT1, ectopic expression of hyperactive DNMT1-DRFTS caused greater malignant transformation and enhanced promoter methylation with condensed chromatin structure that silenced DAPK and DUOX1 expression. Simultaneously, deletion of RFTS impaired DNMT1 chromatin association with pericentromeric Satellite 2 (SAT2) repeat sequences and produced DNA demethylation at SAT2 repeats and globally. To our knowledge, RFTS-deleted DNMT1 is the first single factor that can reprogram focal hypermethylation and global hypomethylation in parallel during malignant transformation. Our evidence suggests that the RFTS domain of DNMT1 is a target responsible for epigenetic changes in cancer.

AB - Site-specific hypermethylation of tumor suppressor genes accompanied by genome-wide hypomethylation are epigenetic hallmarks of malignancy. However, the molecular mechanisms that drive these linked changes in DNA methylation remain obscure. DNA methyltransferase 1 (DNMT1), the principle enzyme responsible for maintaining methylation patterns is commonly dysregulated in tumors. Replication foci targeting sequence (RFTS) is an N-terminal domain of DNMT1 that inhibits DNA-binding and catalytic activity, suggesting that RFTS deletion would result in a gain of DNMT1 function. However, a substantial body of data suggested that RFTS is required for DNMT1 activity. Here, we demonstrate that deletion of RFTS alters DNMT1-dependent DNA methylation during malignant transformation. Compared to full-length DNMT1, ectopic expression of hyperactive DNMT1-DRFTS caused greater malignant transformation and enhanced promoter methylation with condensed chromatin structure that silenced DAPK and DUOX1 expression. Simultaneously, deletion of RFTS impaired DNMT1 chromatin association with pericentromeric Satellite 2 (SAT2) repeat sequences and produced DNA demethylation at SAT2 repeats and globally. To our knowledge, RFTS-deleted DNMT1 is the first single factor that can reprogram focal hypermethylation and global hypomethylation in parallel during malignant transformation. Our evidence suggests that the RFTS domain of DNMT1 is a target responsible for epigenetic changes in cancer.

KW - Chromatin

KW - DNA methylation

KW - DNMT1

KW - RFTS domain

KW - Tumorigenicity

UR - http://www.scopus.com/inward/record.url?scp=84912099856&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84912099856&partnerID=8YFLogxK

U2 - 10.4161/15384101.2014.950886

DO - 10.4161/15384101.2014.950886

M3 - Article

C2 - 25485502

AN - SCOPUS:84912099856

VL - 13

SP - 3222

EP - 3231

JO - Cell Cycle

JF - Cell Cycle

SN - 1538-4101

IS - 20

ER -